KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to $9.5 million.

  • Pacira BioSciences' Change in Inventory rose 1288.71% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year increase of 19847.51%. This contributed to the annual value of $20.9 million for FY2024, which is 15246.08% up from last year.
  • Pacira BioSciences' Change in Inventory amounted to $9.5 million in Q3 2025, which was up 1288.71% from $14.4 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Change in Inventory peaked at $14.4 million during Q2 2025, and registered a low of -$7.6 million during Q1 2024.
  • Over the past 5 years, Pacira BioSciences' median Change in Inventory value was $1.9 million (recorded in 2021), while the average stood at $3.3 million.
  • Data for Pacira BioSciences' Change in Inventory shows a peak YoY increase of 1198837.21% (in 2022) and a maximum YoY decrease of 56717.33% (in 2022) over the last 5 years.
  • Pacira BioSciences' Change in Inventory (Quarter) stood at $1.9 million in 2021, then crashed by 138.54% to -$735000.0 in 2022, then skyrocketed by 1165.71% to $7.8 million in 2023, then surged by 71.29% to $13.4 million in 2024, then fell by 29.1% to $9.5 million in 2025.
  • Its Change in Inventory stands at $9.5 million for Q3 2025, versus $14.4 million for Q2 2025 and $8.5 million for Q1 2025.